790 F. Supp. 2d 313
E.D. Pa.2011Background
- Class action in ED Pa; Plaintiffs ICWF and PTC allege Cephalon marketed Actiq unlawfully, causing third-party payor damages.
- Actiq is a Schedule II fentanyl drug; FDA initially approved for cancer patients, with restrictions against off-label use.
- Plaintiffs seek damages, restitution, and injunctive relief under state consumer protection laws and unjust enrichment theories.
- Choice-of-law analysis: Indiana law governs ICWF; Pennsylvania law governs PTC; unjust enrichment treated as largely non-conflicting.
- Plaintiffs assert extensive off-label marketing and related misconduct; Cephalon seeks summary judgment on several claims.
Issues
| Issue | Plaintiff's Argument | Defendant's Argument | Held |
|---|---|---|---|
| Whether ICWF has standing under IDCSA. | ICWF is a consumer and third-party payor. | ICWF lacks first-party reliance and consumer status. | ICWF has IDCSA standing; third-party payors may sue. |
| Whether ICWF's IDCSA claim requires first-party reliance. | Reliance can be liberal; third-party reliance suffices. | Requiring first-party reliance. | IDCSA does not require first-party reliance; no summary judgment on this basis. |
| Whether ICWF's damages are cognizable under IDCSA. | Damages arise from insurer payments for off-label Actiq prescriptions. | No cognizable injury shown. | Genuine dispute of material fact on cognizable injury remains. |
| Whether PTC has standing under UTPCPL. | PTC purchases for members; third-party payor status allowed. | Learned intermediary and lack of direct purchase. | PTC has UTPCPL standing; genuine fact issues remain on justifiable reliance. |
| Whether unjust enrichment claims survive summary judgment. | Cephalon benefited from third-party payments for Actiq. | Unjust enrichment not viable given tort-like causation. | Unjust enrichment claims proceed; material facts unresolved. |
Key Cases Cited
- Balderston v. Medtronic Sofamor Danek, Inc., 285 F.3d 238 (3d Cir.2002) (purchaser status and causation discussed for medical devices)
- Steamfitters Local Union No. 420 Welfare Fund v. Philip Morris, Inc., 171 F.3d 912 (3d Cir.1999) (unjust enrichment as independent action; proximate causation discussion)
- Hunt v. U.S. Tobacco Co., 538 F.3d 217 (3d Cir.2008) (requires justifiable reliance for UTPCPL claims)
- In re Bextra & Celebrex Mktg. Litig., 495 F. Supp. 2d 1027 (N.D. Cal.2007) (expert marketing/promotion off-label use; reliance on physicians)
- Yocca v. Pittsburgh Steelers Sports, Inc., 854 A.2d 425 (Pa. 2004) (UTPCPL private action elements including reliance)